28.11.2023 14:34:46 - dpa-AFX: *BIOMARIN REPORTS DEAL WITH GERMAN HEALTH INSURANCE FUND ON REIMBURSEMENT AMOUNT FOR ROCTAVIAN FOR SEVERE HEMOPHILIA A

Copyright(c) 2023 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
BioMarin Pharmaceutical 924801 NASDAQ 80,850 06.06.24 22:00:07 +1,180 +1,48% 80,820 80,830 79,020 79,670

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH